BSE filing, NSE: AAVAS. Summary written from the filing by ALFA Finder's alert engine.
Aavas Financiers Ltd: key numbers
- Share price
- ₹1,062.90
- Market cap
- ₹8,428 Cr
- Revenue (annual)
- ₹2,683 Cr
- Net profit (annual)
- ₹654.9 Cr
- P/E (TTM)
- 12.0×Sector 19.8×
- Promoter holding
- 48.88%+0.00% QoQ
- FII holding
- 15.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aavas Financiers Ltd
All →Aavas Financiers Business Update
AAVAS Financiers crossed Rs. 25,000 Crore in Assets Under Management, a milestone with 443 branches and over 3.8 lakh families served. The filing is a press release with no new transaction or financial figures.
Aavas Financiers Debt & Borrowing: ₹22.3 Cr
Aavas Financiers certified timely half-yearly interest payment of ₹22.30 Crore on its NCDs (ISIN INE216P07241). No redemption payment was made during the period.
- Value
- ₹22.30 Cr
Aavas Financiers Regulatory Approval
AAVAS Financiers received an IRDAI Certificate of Registration to act as a Corporate Agent, effective December 8, 2026, and perpetual subject to annual fees. The approval lets the company solicit insurance products to its customers.
- Execution
- Valid from December 08, 2026; perpetual subject to annual fee and compliance
Aavas Financiers Management Change
AAVAS Financiers accepted the resignation of Independent Director Soumya Rajan and HIA Ramachandran Venkatesh, and appointed Anjali Seth as Independent Director and Bharat Thakkar as HIA. A postal ballot for Seth's appointment was also approved.
Aavas Financiers Results Update
AAVAS Financiers released H1FY27 investor highlights, with net profit up 16.4% YoY to ₹3.5 billion. Figures come from a press release, not a full results statement.
Aavas Financiers Investor Presentation: Key Takeaways
H1FY27 PAT ₹3,528mn (+16.4% YoY); Q2FY27 PAT ₹1,815mn (+10.7% YoY). AUM ₹248bn (+16%), Q2 NIM 7.81%. Focus on 20% AUM growth.
Other board meeting date announcements
All →Sanstar Board Meeting Date
Sanstar Ltd has scheduled a board meeting for 5 November 2026 to approve Q2 and H1 FY27 unaudited results. The trading window has been closed since 1 October 2026.
Kilitch Drugs(I) Board Meeting Date
Kilitch Drugs will hold a board meeting on 6 November 2026 to consider unaudited quarterly and half-year results. The trading window stays closed until 48 hours after disclosure.
Foods & Inns Board Meeting Date
Foods and Inns has given prior notice of an audit committee meeting on November 5, 2026, to consider unaudited standalone and consolidated half-yearly results for September 2026. The trading window is closed from October 1 to November 7, 2026.
Hitachi Energy India Board Meeting Date
Hitachi Energy India will hold a board meeting on November 12, 2026 to consider Q2 results. An analyst call is scheduled the same evening.
Euro India Fresh Foods Board Meeting Date
Euro India Fresh Foods has given notice of a board meeting on November 7, 2026, to consider unaudited standalone half-yearly results for September 2026. The trading window stays closed until November 17, 2026.
Axentra Corp Board Meeting Date
Axentra Corp scheduled a board meeting on November 5, 2026 to consider quarterly and half-year results. This advance notice reports no decisions yet.